Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin

Questionable efficacy of the rVSV-ZEBOV Ebola vaccine

(2018) Wolfram G Metzger et al.   LANCET

Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs

(2018) Elena Postnikova et al.   PLoS One

Prevention of Ebola virus disease through vaccination: where we are in 2018

(2018) Yves Lévy et al.   LANCET

Experimental drugs poised for use in Ebola outbreak

(2018) Erika Check Hayden   NATURE

Experimental Therapies for Ebola Virus Disease: What Have We Learned?

(2017) Frederick G. Hayden et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

(2017) Ana Maria Henao-Restrepo et al.   LANCET

Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia

(2017) Stephen B. Kennedy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of N - and O -linked glycosylation patterns of ebolavirus glycoproteins

(2017) Amanda L. Collar et al.   VIROLOGY

The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection

(2017) Elizabeth A. Nelson et al.   PLoS Neglected Tropical Diseases

Combining Yeast Display and Competitive FACS to Select Rare Hapten-Specific Clones from Recombinant Antibody Libraries

(2016) Yue Sun et al.   ANALYTICAL CHEMISTRY

Quinoxaline-based inhibitors of Ebola and Marburg VP40 egress

(2016) H. Marie Loughran et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines

(2016) Iain D. Milligan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry

(2016) Erin E. H. Tran et al.   JOURNAL OF VIROLOGY

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

(2016) Travis K. Warren et al.   NATURE

Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications

(2016) Elizabeth Nelson et al.   Viruses-Basel

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

(2016) Daouda Sissoko et al.   PLOS MEDICINE

Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus

(2016) Yu Cong et al.   PLoS One

Engineering a Therapeutic Lectin by Uncoupling Mitogenicity from Antiviral Activity

(2015) Michael D. Swanson et al.   CELL

A screen of approved drugs and molecular probes identifies therapeutics with anti–Ebola virus activity

(2015) Lisa M. Johansen et al.   Science Translational Medicine

Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate

(2015) Elizabeth Stansell et al.   PLoS One

A Novel Life Cycle Modeling System for Ebola Virus Shows a Genome Length-Dependent Role of VP24 in Virus Infectivity

(2014) A. Watt et al.   JOURNAL OF VIROLOGY

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

(2014) Xiangguo Qiu et al.   NATURE

Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection

(2013) Charles J. Shoemaker et al.   PLoS One

FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection

(2013) L. M. Johansen et al.   Science Translational Medicine

A Lectin Isolated from Bananas Is a Potent Inhibitor of HIV Replication

(2010) Michael D. Swanson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein

(2010) Joseph R. Francica et al.   PLoS Pathogens

Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers

(2008) Sheng-Ce Tao et al.   GLYCOBIOLOGY